The Sonic Healthcare Ltd (ASX: SHL) share price has climbed higher today after the company announced a US$550 million (A$816 million) debt raising.
What are the terms of the capital raising?
Sonic announced that it had priced the US$550 million notes in the United States private placement (USPP) market.
The Aussie healthcare group expects the transaction to close in January 2020 after final due diligence is completed.
The latest debt raising looks set to strengthen the company’s balance sheet while increasing its average debt maturity at a weighted-average fixed coupon of 3.07%.
How has the Sonic Healthcare share price reacted?
The Sonic Healthcare share price has climbed 1.31% higher to $28.58 per share at the time of writing, as investors have been buoyed by the news.
Also helping the company’s shares has been a solid start to the day by the S&P/ASX 200 Index (INDEXASX: XJO), which has climbed 0.14% to 6,55.80 points.
However, the Sonic Healthcare share price has also been a consistent performer over 2019, gaining 31.1% since the start of the year.
When you throw in a 2.94% per annum dividend as well, Sonic is certainly one of the better-looking ASX Healthcare stocks on the market at the moment.
Should you buy Sonic Healthcare shares?
With a market cap of $13.6 billion, Sonic is well and truly among the ASX large-cap stocks.
The company’s shares do trade on a price-to-earnings (P/E) multiple of 23.4x, meaning it could be a little cheap at the moment.
With that in mind, I think Sonic’s position as one of Australia’s largest diagnostic companies and a significant radiology player leaves it well-placed for future growth.
For those Fools seeking some downside portfolio protection from the healthcare sector as well as a strong dividend in the meantime, Sonic could be a good buy.
For those wanting other income options, check out these 3 high-yield ASX stocks below!
With interest rates likely to stay at rock bottom for months (or YEARS) to come, income-minded investors have nowhere to turn... except dividend shares. That’s why The Motley Fool’s top analysts have just prepared a brand-new report, laying out their top 3 dividend bets for 2019.
Hint: These are 3 shares you’ve probably never come across before.
They’re not the banks. Not Woolies or Wesfarmers or any of the “usual suspects.”
We think these 3 shares offer solid growth prospects over the next 12 months. Each of these three companies boasts fully franked yields and could be a great fit for your diversified portfolio. You’ll discover all three names and codes in "The Motley Fool’s Top 3 Dividend Shares for 2019."
Even better, your copy is free when you click the link below. Fair warning: This report is brand new and may not be available forever. Click the link below to be among the first investors to get access to this timely, important new research!
The names of these top 3 dividend bets are all included. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.
Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited and Sonic Healthcare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.